Andy Ellis

519 total citations
14 papers, 326 citations indexed

About

Andy Ellis is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Andy Ellis has authored 14 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Andy Ellis's work include Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Prenatal Screening and Diagnostics (3 papers). Andy Ellis is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Prenatal Screening and Diagnostics (3 papers). Andy Ellis collaborates with scholars based in United Kingdom. Andy Ellis's co-authors include Michael Fahie‐Wilson, R John, Catharine M. Sturgeon, I. K. Sehmi, John Seth, Jenny Hewison, M. F. Scanlon, Rhys John, Louise Bryant and I.F.W. McDowell and has published in prestigious journals such as Clinical Chemistry, BJOG An International Journal of Obstetrics & Gynaecology and Molecular and Cellular Endocrinology.

In The Last Decade

Andy Ellis

13 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Ellis United Kingdom	8	185	70	48	45	33	14	326
Marián Albisu Spain	11	160 0.9×	65 0.9×	61 1.3×	85 1.9×	59 1.8×	16	308
Rachel Webster United Kingdom	10	194 1.0×	25 0.4×	38 0.8×	72 1.6×	19 0.6×	15	330
Ioanna Kosteria Greece	9	77 0.4×	59 0.8×	48 1.0×	38 0.8×	80 2.4×	19	225
Wei Gu China	12	66 0.4×	34 0.5×	57 1.2×	68 1.5×	32 1.0×	36	351
Bakr Bin Sadiq Saudi Arabia	8	118 0.6×	86 1.2×	39 0.8×	37 0.8×	56 1.7×	10	340
S. Davis United States	8	83 0.4×	43 0.6×	22 0.5×	36 0.8×	49 1.5×	14	209
Jennifer L. Kulp United States	11	54 0.3×	55 0.8×	19 0.4×	33 0.7×	14 0.4×	13	316
R. W. V. Flynn United Kingdom	3	200 1.1×	20 0.3×	20 0.4×	29 0.6×	29 0.9×	5	284
Willie M. Bakker‐van Waarde Netherlands	12	236 1.3×	162 2.3×	84 1.8×	122 2.7×	110 3.3×	14	408
Molly O. Regelmann United States	10	103 0.6×	77 1.1×	28 0.6×	115 2.6×	57 1.7×	18	301

Countries citing papers authored by Andy Ellis

Since Specialization

Citations

This map shows the geographic impact of Andy Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Ellis more than expected).

Fields of papers citing papers by Andy Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Ellis. The network helps show where Andy Ellis may publish in the future.

Co-authorship network of co-authors of Andy Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Ellis. A scholar is included among the top collaborators of Andy Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Ellis. Andy Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Burns, Chris, Melanie Moore, Catharine M. Sturgeon, et al.. (2009). WHO International Collaborative Study of the proposed 1 st International Standard for Parathyroid Hormone 1-84 , human, recombinant. 3 indexed citations

Paisley, Angela, et al.. (2007). Pegvisomant interference in GH assays results in underestimation of GH levels. European Journal of Endocrinology. 156(3). 315–319. 34 indexed citations

Sturgeon, Catharine M. & Andy Ellis. (2006). Standardization of FSH, LH and hCG—Current position and future prospects. Molecular and Cellular Endocrinology. 260-262. 301–309. 19 indexed citations

Fahie‐Wilson, Michael, R John, & Andy Ellis. (2005). Macroprolactin; high molecular mass forms of circulating prolactin. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 42(3). 175–192. 101 indexed citations

Reynolds, Tim, Andy Ellis, & Rick Jones. (2004). Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 41(6). 464–468. 6 indexed citations

Bryant, Louise, et al.. (2001). Descriptive information about Down syndrome: a content analysis of serum screening leaflets. Prenatal Diagnosis. 21(12). 1057–1063. 46 indexed citations

Murray, Jenni, Howard Cuckle, I. K. Sehmi, Carol Wilson, & Andy Ellis. (2001). Quality of written information used in Down syndrome screening. Prenatal Diagnosis. 21(2). 138–142. 22 indexed citations

John, Rhys, I.F.W. McDowell, M. F. Scanlon, & Andy Ellis. (2000). Macroprolactin Reactivities in Prolactin Assays: An Issue for Clinical Laboratories and Equipment Manufacturers. Clinical Chemistry. 46(6). 884–885. 32 indexed citations

Seth, John, et al.. (1999). Serum Growth Hormone Measurements in Clinical Practice: An Audit of Performance from the UK National External Quality Assessment Scheme. Hormone Research in Paediatrics. 51(Suppl. 1). 13–19. 37 indexed citations

10.

Lamb, Edmund J., R M Heddle, & Andy Ellis. (1999). Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma. Postgraduate Medical Journal. 75(883). 289–290. 4 indexed citations

11.

Ellis, Andy, et al.. (1999). MACROPROLACTIN-A MAJOR PROBLEM IN IMMUNOASSAYS FOR PROLACTIN. 45. 83–83. 3 indexed citations

12.

Macintosh, M., et al.. (1998). Variation in biochemical screening for Down's syndrome in the United Kingdom. BJOG An International Journal of Obstetrics & Gynaecology. 105(4). 465–467. 7 indexed citations

13.

Seth, J., et al.. (1993). Validation of target values in external quality assessment schemes for peptide hormones and tumour markers. Scandinavian Journal of Clinical and Laboratory Investigation. 53(sup212). 28–30.

14.

Seth, J., et al.. (1991). External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice.. PubMed. 27(3). 443–52. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact